Essa Pharma Stock Crashes After Lead Drug Candidate Trial Flops: Retail Hopes Fade
Richard Glickman, Chairman of Essa’s Board, confirmed that the company is shifting focus to preserve capital, initiating a strategic review Shares of Essa Pharma, Inc. ($EPIX) plummeted 70% on Friday…